WASHINGTON -- Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic ...

The ECDC says the region could still meet its testing targets for HIV, but that it will be harder to improve detection for ...

Enanta Pharmaceuticals recorded a narrower loss as sales rose in its fiscal fourth quarter driven by higher sales of a hepatitis C virus treatment.

Scientists have recently conducted a meta-analysis of over 150 research studies, and determined that infections with viruses ...

Atea Pharmaceuticals, Inc. ( AVIR) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements November 13, 2025 10:00 AM EST Jordan Feld Anthony Martinez Nancy Reau Eric ...

Rowen (not his real name) decided to create a Facebook group dedicated to raising public awareness about liver-related illnesses. Diagnosed with hepatitis B about eight years ago and now in the ...

Until recently, it was not uncommon for Dr. Jeannie Kelly, a high risk obstetrician at Washington University School of Medicine in St. Louis, to diagnose a pregnant patient with Hepatitis C, then ...

Get the latest on Atea Pharmaceuticals’ Q3 2025 earnings, HCV Phase III progress, hepatitis E pipeline expansion, and key financial updates.

Among a large cohort of U.S. veterans, those with chronic hepatitis C virus infection had an increased risk of pancreatic cancer versus those with no infection. Exposure to hepatitis C virus infection ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...